Hepatitis B, Hepatitis C, tuberculosis and sexually-transmitted infections among HIV positive patients in Kazakhstan

Abstract In contrast with global trends, HIV prevalence in Kazakhstan and other Central Asian countries has been rising in recent years. In this study, we analyzed hepatitis B (HBV), hepatitis C (HCV), tuberculosis (TB) and sexually-transmitted (STI) co-infections among 500 HIV positive study partic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ainur Mukhatayeva, Aidana Mustafa, Natalya Dzissyuk, Alpamys Issanov, Bauyrzhan Bayserkin, Sten H. Vermund, Syed Ali
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0103db0e827e41faa2b1146a390adff5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0103db0e827e41faa2b1146a390adff5
record_format dspace
spelling oai:doaj.org-article:0103db0e827e41faa2b1146a390adff52021-12-02T16:10:24ZHepatitis B, Hepatitis C, tuberculosis and sexually-transmitted infections among HIV positive patients in Kazakhstan10.1038/s41598-021-92688-w2045-2322https://doaj.org/article/0103db0e827e41faa2b1146a390adff52021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-92688-whttps://doaj.org/toc/2045-2322Abstract In contrast with global trends, HIV prevalence in Kazakhstan and other Central Asian countries has been rising in recent years. In this study, we analyzed hepatitis B (HBV), hepatitis C (HCV), tuberculosis (TB) and sexually-transmitted (STI) co-infections among 500 HIV positive study participants recruited from all regions of Kazakhstan. Among our study participants, 27%, 8%, 2%, and 5% were coinfected with, respectively, HCV, TB, HBV, and STI. A considerable proportion of the study participants was also found with triple or quadruple infections of HCV/TB (12%), TB/STI (0.8%), HCV/STI (2%), HCV/HBV (1%), HBV/TB (0.4%), HBV/STI (0.2%), HBV/HCV/TB (0.4%), HBV/HCV/STI (0.2%), or HCV/TB/STI (0.2%). Strong associations were found of certain age groups, duration of HIV infection, and practices of injection drug use and sexual contact with PLWH, with co-infections of HIV/HCV and HIV/TB. The odds of having death was 4.07 times higher with TB/HIV as compared to other co-infections. Co-occurrence of HIV with HCV, HBV, and TB infections among participants of this study highlights the necessity of regular screening for HCV infection among HIV infected patients, together with implementation of vigilant vaccination protocols against HBV and TB. Additionally, persons who inject drugs especially need to be focused for harm reduction efforts that include opiate substitution therapy, needle or syringe exchange programs, regular screening, and increased availability of ART and direct acting antivirals.Ainur MukhatayevaAidana MustafaNatalya DzissyukAlpamys IssanovBauyrzhan BayserkinSten H. VermundSyed AliNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ainur Mukhatayeva
Aidana Mustafa
Natalya Dzissyuk
Alpamys Issanov
Bauyrzhan Bayserkin
Sten H. Vermund
Syed Ali
Hepatitis B, Hepatitis C, tuberculosis and sexually-transmitted infections among HIV positive patients in Kazakhstan
description Abstract In contrast with global trends, HIV prevalence in Kazakhstan and other Central Asian countries has been rising in recent years. In this study, we analyzed hepatitis B (HBV), hepatitis C (HCV), tuberculosis (TB) and sexually-transmitted (STI) co-infections among 500 HIV positive study participants recruited from all regions of Kazakhstan. Among our study participants, 27%, 8%, 2%, and 5% were coinfected with, respectively, HCV, TB, HBV, and STI. A considerable proportion of the study participants was also found with triple or quadruple infections of HCV/TB (12%), TB/STI (0.8%), HCV/STI (2%), HCV/HBV (1%), HBV/TB (0.4%), HBV/STI (0.2%), HBV/HCV/TB (0.4%), HBV/HCV/STI (0.2%), or HCV/TB/STI (0.2%). Strong associations were found of certain age groups, duration of HIV infection, and practices of injection drug use and sexual contact with PLWH, with co-infections of HIV/HCV and HIV/TB. The odds of having death was 4.07 times higher with TB/HIV as compared to other co-infections. Co-occurrence of HIV with HCV, HBV, and TB infections among participants of this study highlights the necessity of regular screening for HCV infection among HIV infected patients, together with implementation of vigilant vaccination protocols against HBV and TB. Additionally, persons who inject drugs especially need to be focused for harm reduction efforts that include opiate substitution therapy, needle or syringe exchange programs, regular screening, and increased availability of ART and direct acting antivirals.
format article
author Ainur Mukhatayeva
Aidana Mustafa
Natalya Dzissyuk
Alpamys Issanov
Bauyrzhan Bayserkin
Sten H. Vermund
Syed Ali
author_facet Ainur Mukhatayeva
Aidana Mustafa
Natalya Dzissyuk
Alpamys Issanov
Bauyrzhan Bayserkin
Sten H. Vermund
Syed Ali
author_sort Ainur Mukhatayeva
title Hepatitis B, Hepatitis C, tuberculosis and sexually-transmitted infections among HIV positive patients in Kazakhstan
title_short Hepatitis B, Hepatitis C, tuberculosis and sexually-transmitted infections among HIV positive patients in Kazakhstan
title_full Hepatitis B, Hepatitis C, tuberculosis and sexually-transmitted infections among HIV positive patients in Kazakhstan
title_fullStr Hepatitis B, Hepatitis C, tuberculosis and sexually-transmitted infections among HIV positive patients in Kazakhstan
title_full_unstemmed Hepatitis B, Hepatitis C, tuberculosis and sexually-transmitted infections among HIV positive patients in Kazakhstan
title_sort hepatitis b, hepatitis c, tuberculosis and sexually-transmitted infections among hiv positive patients in kazakhstan
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/0103db0e827e41faa2b1146a390adff5
work_keys_str_mv AT ainurmukhatayeva hepatitisbhepatitisctuberculosisandsexuallytransmittedinfectionsamonghivpositivepatientsinkazakhstan
AT aidanamustafa hepatitisbhepatitisctuberculosisandsexuallytransmittedinfectionsamonghivpositivepatientsinkazakhstan
AT natalyadzissyuk hepatitisbhepatitisctuberculosisandsexuallytransmittedinfectionsamonghivpositivepatientsinkazakhstan
AT alpamysissanov hepatitisbhepatitisctuberculosisandsexuallytransmittedinfectionsamonghivpositivepatientsinkazakhstan
AT bauyrzhanbayserkin hepatitisbhepatitisctuberculosisandsexuallytransmittedinfectionsamonghivpositivepatientsinkazakhstan
AT stenhvermund hepatitisbhepatitisctuberculosisandsexuallytransmittedinfectionsamonghivpositivepatientsinkazakhstan
AT syedali hepatitisbhepatitisctuberculosisandsexuallytransmittedinfectionsamonghivpositivepatientsinkazakhstan
_version_ 1718384390306791424